The Scientific Review Board reviews all grant applications submitted to the ADDF. It is composed of over 150 scientists who possess expertise in multiple areas of Alzheimer’s research.

A-E


Carmela Abraham, PhD

Boston University School of Medicine

Larry D. Altstiel, MD, PhD

Provectra Therapeutics, Inc.

Ottavio Arancio, MD, PhD

Columbia University

Stephen P. Arnerić, PhD

Critical Path Institute

Kelly Bales, PhD

Pfizer Inc

Nir Barzilai, MD

Albert Einstein College of Medicine

Guriq Basi, PhD

Elan Pharmaceuticals

Dirk Beher, PhD

Asceneuron SA

David A. Bennett, MD

Rush University Medical Center

Narayan Bhat, PhD

Medical University of South Carolina

Jennifer Bizon, PhD

McKnight Brain Research Foundation

Chas Bountra, PhD

University of Oxford

Adam Boxer, MD, PhD

University of California, San Francisco

Roberta Diaz Brinton, PhD

Chair in Therapeutic Discovery and Development and Professor of Pharmacology and Pharmaceutical Sciences, Biomedical Engineering and Neurology, University of Southern California

Tilmann Brotz, PhD

Konzept Drug Development Consulting

Kurt Brunden, PhD

University of Pennsylvania

Nigel Cairns, PhD

Washington University

Thomas Chung, PhD

Sanford-Burnham Medical Research Institute

John Cirrito, PhD

Washington University, St. Louis

Thomas Cirrito, PhD

Stemline Therapeutics, Inc.

Mark A. Cochran, PhD

Johns Hopkins University School of Medicine

Jerry Colca, PhD

Metabolic Solutions Development Company

Greg M. Cole, PhD

UCLA School of Medicine

Carol Colton, PhD

Duke University Medical Center

Jeffrey L. Cummings, MD

University of California, Los Angeles

Alpaslan Dedeoglu, MD, PhD

Boston University School of Medicine

Matthew DeLisa, PhD

Cornell University

Joel Dudley, PhD

Icahn School of Medicine at Mount Sinai

Christopher B. Eckman, PhD

Mayo Clinic

Steve Estus, PhD

University of Kentucky

F-J


Martin Farlow, MD

Indiana University School of Medicine

Luca Ferraro, Pharm.D.

University of Ferrara

Massimo Filippi, MD

Fondanzione Centro San Raffaele

Abraham Fisher, PhD

Israel Institute for Biological Research

Paul E. Fraser, PhD

University of Toronto

Robert P. Friedland, MD

University of Louisville

Douglas R. Galasko, MD

University of California, San Diego

Samuel Gandy, MD, PhD

Mount Sinai School of Medicine

Thota Ganesh, PhD

Emory University

Hugo Geerts, PhD

In Silico Biosciences, Inc.

Ezio Giacobini, MD, PhD

Geneva University Hospitals

Gary Gibson, PhD

Winifred Masterson Burke Medical Research Institute

Paul Gilligan, PhD

Pennsylvania Drug Discovery Institute

Marcie A. Glicksman, PhD

Harvard Neurodiscovery Center

Todd E. Golde, MD, PhD

Mayo Clinic

Jennifer Goldman, MD, MS

Rush University Medical Center

Gunnar K. Gouras, MD

Weill Medical College of Cornell University

Illana Gozes, PhD

Tel Aviv University

Allan M. Green, MD, PhD, JD

Allan M. Green Esq., LLC

Barry D. Greenberg, PhD

University Health Network

Milton L. Greenberg, PhD

Vivreon Biosciences, LLC

Francine Grodstein, ScD

Brigham and Women's Hospital

John Hardy, PhD

UCL Institute of Neurology

Joseph A. Helpern, PhD

Medical University of South Carolina

Jim Hendrix, PhD

Alzheimer's Association

Lawrence Honig, MD, PhD

Columbia University

Orest Hurko, MD

Biologics Consulting Group, Inc.

Xiong Jiang, PhD

Georgetown University

Carl Johnson, PhD

Hereditary Disease Foundation

Corinne Jolivalt, PhD

University of Southern California, San Diego

K-M


Andrew Kertesz, MD

University of Western Ontario

Tae-Wan Kim, PhD

Columbia University Medical Center

Alexander Kiselyov, PhD

ChemDiv, Inc.

David Knopman, MD

Mayo Clinic Rochester

Sam Kongsamut, PhD

Rudder Serendip LLC

Amos Korczyn, MD

RAMOT of Tel Aviv University

Dora M. Kovacs, PHD

Massachusetts General Hospital

Alan P. Kozikowski, PhD

University of Illinois at Chicago

Arthur F. Kramer, PhD

University of Illinois

Jeff A. Kuret, PhD

Ohio State University

Krista Lanctôt, PhD

Sunnybrook Research Institute, University of Toronto

Gary Landreth, PhD

Case Western Reserve University School of Medicine

Allan Levey, MD, PhD

Emory University School of Medicine

Ling Li, DVM, PhD

University of Minnesota

John Lincecum, PhD

ALS Therapy Development Institute

Dane R. Liston, PhD

The National Cancer Institute

Donald Lo, PhD

Duke University Medical Center

David Lowe, PhD

NeuroAssets

Joan Mackell, PhD

Pfizer, Inc.

Tamara Maes, PhD

Oryzon Genomics

Alexandros Makriyannis, PhD

Northeastern University

Eliezer Masliah, PhD

University of California, San Diego

Doug Matthews, PhD

Nanyang Technological University

Patrick C. May, PhD

Eli Lilly and Company

Olga Meulenbroek, PhD

Radboud University Medical Center

Elias K. Michaelis, MD, PhD

University of Kansas

Michelle Mielke, PhD

Mayo Clinic

Bruce L. Miller, MD

University of California, San Francisco

Richard Mohs, PhD

Retired Vice President for Neuroscience Early Clinical Development and Distinguished Research Fellow, Eli Lilly & Company

Perry B. Molinoff, MD

University of Pennsylvania

N-R


Peter Nelson, MD, PhD

University of Kentucky

Ian Newington, PhD

GE Healthcare

Alan W. O’Connell, PhD

Seroba Life Sciences

Salvatore Oddo, PhD

Banner Sun Health Research Institute

Gary Olson, PhD

Provid Pharmaceuticals Inc.

Ana Pereira, MD

The Rockefeller University

Yukari Perrella, MBA

Yuma Therapeutics Corporation

George Perry, PhD

University of Texas at San Antonio

Gregory Petsko, PhD

Brandeis University

Pavel Petukhov, PhD

University of Illinois at Chicago

Paolo Pevarello, PhD

Axxam SpA

Nathalie Pochet, PhD

Brigham & Women's Hospital

Donald L. Price, MD

Johns Hopkins University

Sathyanarayanan Puthanveettil, PhD

Scripps Research Institute

William J. Ray, PhD

MD Anderson Cancer Center

G. William Rebeck, PhD

Georgetown University School of Medicine

Thadd Reeder, PhD

Glialogix, Inc.

Eric Reiman, MD

Banner Good Samaritan Medical Center

Nikolaos K. Robakis, PhD

Mount Sinai School of Medicine

Blaine Roberts, PhD

University of Melbourne

Jack T. Rogers, PhD

Massachusetts General Hospital

Jerri Rook, PhD

Vanderbilt Center for Neuroscience Drug Discovery

Sharon Rosenzweig-Lipson,PhD

AgeneBio

Gerard Rosse, PhD

Dart Neuroscience

S-Z


Linda Van Eldik, PhD

University of Kentucky

Barbara Sahagan, PhD

Sahagan Biomedical Consulting

Kumar Sambamurti, PhD

Medical University of South Carolina

Joel Schachter, PhD

Merck Research Laboratories

Richard Scheyer, MD

Elias (Elliot) M. Schwam, PhD

Pfizer Inc

Raj Shah, MD

Rush University Medical Center

John Shoffner, MD

Medical Neurogenetics

Einar M. Sigurdsson, PhD

New York University School of Medicine

Ely Simon, MD

NeuroTrax Corporation

Edward Spack, PhD

Fast Forward LLC

Reisa Sperling, MD

Harvard Medical School

Yaakov Stern, PhD

Columbia University

Joel L. Sussman, PhD

The Weizmann Institute of Science

Malu Tansey, PhD

Emory University

Pierre Tariot, MD

Banner Good Samaritan Medical Center

Andrea J. Tenner, PhD

University of California, Irvine

Georg Terstappen, PhD

Neuroscience Discovery

Greg R. J. Thatcher, PhD

University of Illinois at Chicago

Martin Tolar, MD, PhD

Alzheon, Inc.

Eugenia Trushina, PhD

Mayo Clinic Rochester

Katya Tsaloun, PhD

Cyprotex

Neil Vasdev, PhD

Massachusetts General Hospital

Austin Yang, PhD

University of Maryland

Sung Ok Yoon, PhD

Ohio State University

W. Haung (Ho) Yu, PhD

Taub Institute - Columbia University

Yan Zhang, PhD

University of Texas, Austin